Australian healthcare company InhaleRx (ASX: IRX) has achieved significant advancements in its clinical trials involving cannabinoid (CBD)-derived drugs. The company has taken meaningful steps forward in...
Tag: CBD
Avecho Biotechnology Commences Manufacturing for Capsules
Avecho Biotechnology (ASX:AVE), an Australian biotechnology company specializing in innovative pharmaceutical solutions, has embarked on a pivotal Phase III clinical trial for its oral cannabidoil (CBD)...